VALCAMONICO, Francesca
 Distribuzione geografica
Continente #
NA - Nord America 671
EU - Europa 205
AS - Asia 181
OC - Oceania 3
Totale 1.060
Nazione #
US - Stati Uniti d'America 670
CN - Cina 66
SG - Singapore 59
DE - Germania 45
IT - Italia 44
UA - Ucraina 34
FI - Finlandia 27
HK - Hong Kong 20
TR - Turchia 17
GB - Regno Unito 16
IE - Irlanda 14
SE - Svezia 10
IN - India 6
FR - Francia 4
ID - Indonesia 4
RU - Federazione Russa 4
VN - Vietnam 4
AU - Australia 3
CZ - Repubblica Ceca 3
IR - Iran 2
PL - Polonia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
BE - Belgio 1
CA - Canada 1
KW - Kuwait 1
Totale 1.060
Città #
Fairfield 83
Ashburn 78
Singapore 51
Woodbridge 46
Seattle 43
Houston 41
Ann Arbor 36
Cambridge 34
Chandler 32
Jacksonville 28
New York 27
Wilmington 27
Helsinki 25
Princeton 24
Hong Kong 20
Beijing 16
Istanbul 16
Dublin 14
Boardman 13
Dearborn 10
Shanghai 10
Washington 10
Brescia 9
Los Angeles 8
Des Moines 7
Munich 7
Nanjing 7
Romola 5
San Mateo 5
Dong Ket 4
Jakarta 4
London 4
San Diego 4
Santa Clara 4
Melbourne 3
Nanchang 3
Ardabil 2
Bologna 2
Brno 2
Changsha 2
Chiswick 2
Dalmine 2
Highland 2
Jiaxing 2
Kilburn 2
Kunming 2
Lancaster 2
Mantova 2
Milan 2
Norwalk 2
Pisogne 2
San Francisco 2
Shenyang 2
Verona 2
Warsaw 2
West Jordan 2
Acton 1
Augusta 1
Baku 1
Bareggio 1
Brussels 1
Cazzago San Martino 1
Chengdu 1
Cleveland 1
Erbusco 1
Esslingen am Neckar 1
Frankfurt am Main 1
Guangzhou 1
Haikou 1
Hebei 1
Iseo 1
Jinan 1
Kuwait City 1
Lappeenranta 1
Leawood 1
Nürnberg 1
Olomouc 1
Orange 1
Pune 1
Redmond 1
Redwood City 1
Sant'anastasia 1
Secaucus 1
Southwark 1
Taizhou 1
Tianjin 1
Tirana 1
Toronto 1
Villa di Briano 1
Véry 1
Totale 832
Nome #
Amiloride Is Effective in the Management of Abiraterone-Induced Mineralocorticoid Excess Syndrome without Interfering with Its Antineoplastic Activity 128
Serum vitamin D and prostate cancer prognosis: The story continues 123
Is time to first skeletal-related event the best primary end point in the assessment of bisphosphonate efficacy in patients with castration-sensitive prostate cancer? 115
Gonadal function in male patients with metastatic renal cell cancer treated with sunitinib: Effects of testosterone replacement on quality of life. 106
The Spread of SARS-CoV-2 Infection Among the Medical Oncology Staff of ASST Spedali Civili of Brescia: Efficacy of Preventive Measures 96
When Less Is More: Specific Capture and Analysis of Tumor Exosomes in Plasma Increases the Sensitivity of Liquid Biopsy for Comprehensive Detection of Multiple Androgen Receptor Phenotypes in Advanced Prostate Cancer Patients 73
Non-metastatic ductal adenocarcinoma of the prostate: pattern of care from an uro-oncology multidisciplinary group 69
Changes in body composition and lipid profile in prostate cancer patients without bone metastases given Degarelix treatment: the BLADE prospective cohort study 62
Is androgen deprivation therapy protective against SARS-CoV-2 infection and related complications in prostate cancer patients? 60
Cisplatin Cytotoxicity in Human Testicular Germ Cell Tumor Cell Lines Is Enhanced by the CDK4/6 Inhibitor Palbociclib 49
Gonadal Function in Male Patients With Metastatic Renal Cell Cancer Treated With Sunitinib 42
Maintenance versus discontinuation of androgen deprivation therapy during continuous or intermittent docetaxel administration in castration-resistant prostate cancer patients: A multicentre, randomised Phase III study by the Piemonte Oncology Network 38
Effect of Degarelix administration on bone health in prostate cancer patients without bone metastases. The Blade study 31
Is BMI a reliable prognostic parameter in metastatic prostate cancer patients? 29
Maintenance of androgen deprivation therapy or testosterone supplementation in the management of castration-resistant prostate cancer: that is the question 28
null 13
Pathological Complete Response to Pembrolizumab plus Axitinib Combination following Serious Immune-Related Adverse Events in an Advanced Renal Cell Carcinoma Patient with a History of Rheumatoid Arthritis 11
Heterogeneity in regional changes in body composition induced by androgen deprivation therapy in prostate cancer patients: potential impact on bone health-the BLADE study 9
Osteoblastic flare in a patient with advanced gastric cancer after treatment with pemetrexed and oxaliplatin: implications for response assessment with RECIST criteria 9
Long-lasting successful cerebral response with sorafenib in advanced renal cell carcinoma 7
Totale 1.098
Categoria #
all - tutte 7.381
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.381


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020104 0 0 0 0 8 18 17 15 11 21 7 7
2020/2021208 4 7 9 46 5 21 22 16 16 27 22 13
2021/2022133 9 30 5 6 7 8 6 10 2 10 12 28
2022/2023115 14 3 8 8 9 23 1 10 23 0 4 12
2023/2024232 11 7 25 17 16 57 11 18 24 10 2 34
2024/2025127 3 9 5 67 43 0 0 0 0 0 0 0
Totale 1.098